Is my patient with urothelial cancer (in)eligible for platinum?

Urol Oncol. 2024 Feb;42(2):27. doi: 10.1016/j.urolonc.2023.12.015. Epub 2024 Jan 8.

Authors

Irfan Karahan¹, Burak Bilgin²

Affiliations

¹ Department of Medical Oncology, Ankara Bilkent City Hospital, Ankara, Turkey. Electronic address: [email protected].
² Department of Medical Oncology, Ankara Bilkent City Hospital, Ankara, Turkey.

PMID: 38195329
DOI: 10.1016/j.urolonc.2023.12.015

No abstract available

Publication types

Letter

MeSH terms

Antineoplastic Combined Chemotherapy Protocols
Carcinoma, Transitional Cell* / drug therapy
Humans
Platinum / therapeutic use
Urinary Bladder Neoplasms* / drug therapy

Substances

Platinum